Thrombomodulin and tissue factor pathway inhibitor levels as risk factors in patients with essential hypertension
โ Scribed by Th.K. Makris; P.G. Krespi; G.P. Anastasiadis; T. Dodouras; P. Triposikiadis; A.N. Hatzizaharias; A. Perrakis; M.K. Kynakids
- Book ID
- 118589001
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 140 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1558-3597
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPI and vascular endothelial cell injury. Plasma TF (273 ยฑ 90 pg/ml) and TFPI (252 ยฑ 125 ng/ml) levels wer
We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPl and vascular endothelial cell injury. Plasma TF (273 2 90 pg/ml) and TFPl (252 2 125 nglml) levels wer